The Ministry of Health revealed in its daily COVID-19 update this afternoon (Saturday 30th October 2021) that there are 290 new COVID-19 cases in Trinidad and Tobago plus eight (8) additional deaths. These new patients will be processed for admission at the discretion of the CMOHs. The number of new cases represents a 1.75% increase in reported cases from yesterday.
There have been 6,412 new cases and 200 deaths so far in the month of October. The Ministry reported 285 new cases yesterday plus six (6) more unfortunate deaths. The country’s death toll has increased to 1,682. T&T’s total positive cases now rises to 57,121, with 4,874 being active cases. A total of 50,565 patients have recovered from the virus to date. 4,209 persons are in home self-isolation and there are sixty-seven (67) persons in total at State quarantine facilities. A total of 622,626 persons have been partially vaccinated with a first dose and 600,601 have been fully vaccinated (including single-dose Johnson & Johnson). The percentage of patients in the parallel healthcare system who are NOT fully vaccinated is 93.7% (based on data from 22nd July - 13th October 2021). The Ministry states that the number of positive cases reported reflects the samples taken during the period 26th - 29th October 2021 and not the last twenty-four (24) hours. The Ministry also notes that there are currently 344 COVID-19 positive patients being treated at Hospitals with twenty-one (21) in the Intensive Care Unit (ICU) and fourteen (14) in the High Dependency Unit (HDU). Thirty-one (31) patients are in step-down/transition facilities across T&T. This is a developing story - refresh this page for updates.
0 Comments
The Ministry of Health held a virtual Press Conference at 11am this morning (Saturday 30th October 2021) to update the public on the latest developments with COVID-19 in Trinidad and Tobago. Below are the key points discussed today, courtesy of TTT Live Online: - Full service (with consumption of alcohol on premises ONLY) will resume at restaurants and other facilities operating within the Safe Zones from Monday 1st November 2021. Capacity remains at 50%. - While Trinidad and Tobago has crossed the 600,000 threshold of completed COVID-19 vaccinations, Health Minister Terrence Deyalsingh is expressing concern over the slowing down of persons coming in for their first COVID-19 shot. He is appealing to the unvaccinated population to make vaccination part of their civic duty. - As of this morning, fifty-one (51) out of fifty-four (54) beds in the parallel healthcare system in Trinidad are occupied by COVID-19 patients. Of those fifty-one (51) patients in the system, forty-eight (48) are not fully vaccinated. - As of this morning, there are nineteen (19) patients across the traditional Accident & Emergency (A&E) departments who require immediate transfer to Hospitals in the parallel healthcare system. Seven (7) of these nineteen (19) patients require Intensive Care Unit (ICU) care. - Principal Medical Officer of Institutions, Dr. Maryam Abdool-Richards, noted that persons continue to come to A&E departments in a severe and critical medical state, requiring immediate ICU care (ventilatory support) for COVID-19. She said the average number of patients requiring ICU care is between five (5) and seven (7) patients. - The Trinidad and Tobago Non-Communicable Diseases Alliance (TTNCDA) has, with the support of PAHO, launched a COVID-19 vaccine hesitancy hotline, 607-VAXX. This virtual call centre is staffed by Doctors. If you missed the Press Conference, you can watch it below in its entirety. This is a developing story - refresh this page for updates. [Source: TTT Live Online]
According to a leaked internal memorandum which was sent to all KFC Restaurant General Managers, KFC delivery fees will increase from $15 per order to $20 per order effective from Monday 1st November 2021. The change in delivery fee has not yet been publicly announced by the company. The internal memo advised the following response should be used if any customer has complaints or questions about the hike in delivery fee: "In light of all the changes during the Pandemic and the subsequent impact on our business, we have had to align our delivery fees within the industry range. And while we do understand that this increase will impact our customers, we have done our best to keep cost at minimum. As always, we thank you for choosing KFC and look forward to delivering quality food and service today as well as the future." Delivery drivers, according to the internal memo, will also see an increase in their rate per delivery, from $10 per delivery to $18. The memo notes, "As a result, we will no longer be paying the $20 gas allowance per hour." With this increase in delivery fee to $20, other food outlets providing delivery services may also soon adopt this new fee. Will you continue ordering from KFC for delivery, or will you use drive-thru more in light of this change? Let us know your thoughts in the comments below. This is a developing story - refresh this page for updates. [Source: Loop]
The Ministry of Health will be hosting a virtual Press Conference at 11am this morning (Saturday 30th October 2021) to update the public about the latest developments with COVID-19 in Trinidad and Tobago.
The Ministry reported 285 new cases yesterday along with six (6) more unfortunate deaths. The country’s death toll has reached 1,674. There have been 6,122 new cases and 192 deaths so far in the month of October. Both figures are already higher than the entire month of September. Watch the live stream of the Press Conference below when it begins at 11am, courtesy of TTT.
This is a developing story - refresh this page for updates.
Today (Friday 29th October 2021), the U.S. Food and Drug Administration (FDA) officially authorized the emergency use of the Pfizer-BioNTech COVID-19 vaccine to include children five (5) through eleven (11) years of age. The authorization was based on the FDA’s thorough and transparent evaluation of the data that included input from independent advisory committee experts who overwhelmingly voted in favor of making the vaccine available to children in this age group. Key points for parents and caregivers:
“As a mother and a physician, I know that parents, caregivers, school staff, and children have been waiting for today’s authorization. Vaccinating younger children against COVID-19 will bring us closer to returning to a sense of normalcy,” said Acting FDA Commissioner Janet Woodcock, M.D. “Our comprehensive and rigorous evaluation of the data pertaining to the vaccine’s safety and effectiveness should help assure parents and guardians that this vaccine meets our high standards.” The Pfizer-BioNTech COVID-19 Vaccine for children five (5) through eleven (11) years of age is administered as a two-dose primary series, three (3) weeks apart, but is a lower dose (10 micrograms) than that used for individuals twelve (12) years of age and older (30 micrograms). In the U.S., COVID-19 cases in children five (5) through eleven (11) years of age make up 39% of cases in individuals younger than eighteen (18) years of age. According to the CDC, approximately 8,300 COVID-19 cases in children five (5) through eleven (11) years of age resulted in hospitalization. As of 17th October 2021, 691 deaths from COVID-19 have been reported in the U.S. in individuals less than eighteen (18) years of age, with 146 deaths in the five (5) through eleven (11) years age group. “The FDA is committed to making decisions that are guided by science that the public and healthcare community can trust. We are confident in the safety, effectiveness and manufacturing data behind this authorization. As part of our commitment to transparency around our decision-making, which included our public advisory committee meeting earlier this week, we have posted documents today supporting our decision and additional information detailing our evaluation of the data will be posted soon. We hope this information helps build confidence of parents who are deciding whether to have their children vaccinated,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research. The FDA has determined this Pfizer vaccine has met the criteria for emergency use authorization. Based on the totality of scientific evidence available, the known and potential benefits of the Pfizer-BioNTech COVID-19 vaccine in individuals down to five (5) years of age outweigh the known and potential risks. FDA Evaluation of Available Effectiveness Data The effectiveness data to support the EUA in children down to five (5) years of age is based on an ongoing randomized, placebo-controlled study that has enrolled approximately 4,700 children five (5) through eleven (11) years of age. The study is being conducted in the U.S., Finland, Poland and Spain. Children in the vaccine group received two (2) doses of the Pfizer-BioNTech COVID-19 vaccine containing ten (10) micrograms of messenger RNA per dose. The FDA analyzed data that compared the immune response of 264 participants from this study to 253 participants sixteen (16) through twenty-five (25) years of age who had two (2) higher doses of the vaccine in a previous study which determined the vaccine to be effective in preventing COVID-19. The immune responses of the younger age participants were comparable to the older participants. The FDA also conducted a preliminary analysis of cases of COVID-19 occurring seven (7) days after the second dose. In this analysis, among participants without evidence of prior infection with SARS-CoV-2, 3 cases of COVID-19 occurred among 1,305 vaccine recipients and sixteen (16) cases of COVID-19 occurred among 663 placebo recipients; the vaccine was 90.7% effective in preventing COVID-19. FDA Evaluation of Available Safety Data The available safety data to support the EUA include more than 4,600 participants (3,100 vaccine, 1,538 placebo) ages five (5) through eleven (11) years enrolled in the ongoing study. In this trial, a total of 1,444 vaccine recipients were followed for safety for at least two (2) months after the second dose. Commonly reported side effects in the clinical trial included injection site pain (sore arm), redness and swelling, fatigue, headache, muscle and/or joint pain, chills, fever, swollen lymph nodes, nausea and decreased appetite. More children reported side effects after the second dose than after the first dose. Side effects were generally mild to moderate in severity and occurred within two (2) days after vaccination, and most went away within one (1) to two (2) days. The FDA and CDC safety surveillance systems have previously identified increased risks of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of tissue surrounding the heart) following vaccination with Pfizer-BioNTech COVID-19 vaccine, particularly following the second dose, and with the observed risk highest in males twelve (12) through seventeen (17) years of age. Therefore, the FDA conducted its own benefit-risk assessment using modelling to predict how many symptomatic COVID-19 cases, hospitalizations, Intensive Care Unit (ICU) admissions and deaths from COVID-19 the vaccine in children five (5) through eleven (11) years of age would prevent versus the number of potential myocarditis cases, hospitalizations, ICU admissions and deaths that the vaccine might cause. The FDA’s model predicts that overall, the benefits of the vaccine would outweigh its risks in children five (5) through eleven (11) years of age. Ongoing Safety Monitoring Pfizer Inc. has updated its safety monitoring plan to include evaluation of myocarditis, pericarditis and other events of interest in children five (5) through eleven (11) years of age. In addition, the FDA and the CDC have several systems in place to continually monitor COVID-19 vaccine safety and allow for the rapid detection and investigation of potential safety problems. It is mandatory for Pfizer Inc. and vaccination providers to report any serious adverse events, cases of Multisystem Inflammatory Syndrome and cases of COVID-19 that result in hospitalization or death in vaccinated individuals. It is also mandatory for vaccination providers to report all vaccine administration errors to VAERS for which they become aware and for Pfizer Inc. to include a summary and analysis of all identified vaccine administration errors in monthly safety reports to the FDA. Data Supports New Vaccine Formulation to Improve Stability and Storage Conditions The FDA today also authorized a manufacturing change for the vaccine to include a formulation that uses a different buffer; buffers help maintain a vaccine’s pH (a measure of how acidic or alkaline a solution is) and stability. This new formulation is more stable at refrigerated temperatures for longer periods of time, permitting greater flexibility for vaccination providers. The new formulation of the vaccine developed by Pfizer Inc. contains Tris buffer, a commonly used buffer in a variety of other FDA-approved vaccines and other biologics, including products for use in children. The FDA evaluated manufacturing data to support the use of Pfizer-BioNTech COVID-19 vaccine containing Tris buffer and concluded it does not present safety or effectiveness concerns. This is a developing story - refresh this page for updates. [Source: FDA]
Police have arrested five (5) additional suspects in connection with the robbery and homicide that occurred yesterday (Thursday 28th October 2021) along the Valencia Old Road.
According to the Trinidad and Tobago Police Service (TTPS), seven (7) persons are currently assisting the Northern and Eastern Division Officers with their investigation into the robbery. The additional suspects are three (3) 21-year-olds, two (2) from Valencia, and one (1) from Marabella, as well as a 22-year-old from Depeza Trace, Valencia. A total of seven (7) persons have been arrested thus far, three (3) guns seized and one (1) vehicle recovered in connection with the robbery and homicide. According to reports around 7pm on Thursday night, a party of Officers from the Northern Division conducted investigations into the robbery and homicide. The Officers received certain information which led them to Gill Street, Valencia. Upon arrival at the location, the Officers made certain observations and a 22-year-old woman was arrested and taken to the Valencia Police Post. Other Units involved in the arrest and investigations are the Special Intelligence Unit, Eastern Division, Northern Division Task Force-East (NDTF-E), Multi-Operational Police Section (MOPS), and the Air Support Unit. Investigations are ongoing. The Ministry of Health revealed in its daily COVID-19 update this afternoon (Friday 29th October 2021) that there are 285 new COVID-19 cases in Trinidad and Tobago plus six (6) additional deaths. These new patients will be processed for admission at the discretion of the CMOHs. The number of new cases represents a 26.17% decrease in reported cases from yesterday.
There have been 6,122 new cases and 192 deaths so far in the month of October. The Ministry reported 386 new cases yesterday plus ten (10) more unfortunate deaths. The country’s death toll has increased to 1,674. T&T’s total positive cases now rises to 56,831, with 4,777 being active cases. A total of 50,380 patients have recovered from the virus to date. 4,123 persons are in home self-isolation and there are sixty-one (61) persons in total at State quarantine facilities. A total of 621,772 persons have been partially vaccinated with a first dose and 597,499 have been fully vaccinated (including single-dose Johnson & Johnson). The percentage of patients in the parallel healthcare system who are NOT fully vaccinated is 93.7% (based on data from 22nd July - 13th October 2021). The Ministry states that the number of positive cases reported reflects the samples taken during the period 25th - 28th October 2021 and not the last twenty-four (24) hours. The Ministry also notes that there are currently 339 COVID-19 positive patients being treated at Hospitals with twenty (20) in the Intensive Care Unit (ICU) and eighteen (18) in the High Dependency Unit (HDU). Thirty (30) patients are in step-down/transition facilities across T&T. This is a developing story - refresh this page for updates. Police are investigating an incident which occurred on Thursday (28th October 2021) in El Socorro involving a couple which resulted in a woman sustaining injuries.
According to the Trinidad and Tobago Police Service (TTPS) at 11am on Thursday, a woman of El Socorro reported to Police that a man known to her, who was driving a white Nissan B-15 motor vehicle, stopped alongside her following which an argument ensued. During the argument, Police were told, the exchange escalated and, as a result, the man allegedly held onto her hand while driving causing her to be dragged a few feet alongside his vehicle. The man reportedly released her hand a short distance away causing the injured woman to lay on the roadway until she was assisted by good samaritans. Officers of the Emergency Response Patrol, North-Eastern Division, later arrived on the scene and escorted the woman to the Eric Williams Medical Sciences Complex, Mt. Hope, where she is currently being treated for her injuries. San Juan Police are continuing investigations into the incident. A male passenger between the age of thirty-five (35) to forty-five (45), died during a flight on a Caribbean Airlines (CAL) aircraft which was en route to Barbados on Thursday (28th October 2021). Passengers on that flight told Guardian Media the man was discovered unconscious in the aircraft’s toilet after flight attendants decided to check on him, due to the length of time he was in there. A Doctor onboard the flight tried to revive the man, who eventually started talking. However, the man subsequently died. The aircraft made its scheduled stop in Barbados and continued on to its other destinations, including the United States. When contacted by Guardian Media, CAL confirmed the incident, stating, “There was a medical emergency. The crew followed all the relevant operating procedures but regrettably the passenger expired. CAL extends condolence to the family and loved ones of the deceased.” [Source: CNC3]
The Ministry of Health is advising the population that Trinidad and Tobago has confirmed thirty-four (34) new cases of the COVID-19 Delta Variant of Concern (VOC). This brings the total number of cases of the COVID-19 Delta variant, which have been confirmed for T&T, to 136. The announcement was made this evening (Thursday 28th October 2021) alongside today’s alarming COVID-19 update. The Ministry provided the following breakdown of these thirty-four (34) cases:
The presence of the Delta variant was confirmed via gene sequencing at the laboratory of the Faculty of Medical Sciences, University of the West Indies, The Ministry said all related protocols are being observed. This is a developing story - refresh this page for updates.
|
AboutYouthere1 is a website focused on providing useful information, breaking news, entertainment and online shopping in Trinidad and Tobago.
AlertsSupportYouTubeContactPrivacyCategories
All
Archives
March 2024
|
© 2024 Youthere1 Enterprises. All Rights Reserved.